# Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room

> **NCT01517828** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 62 (actual)

## Conditions studied

- Respiratory Distress Syndrome
- Prematurity of Fetus

## Interventions

- **DRUG:** Sedation by ketamine
- **DRUG:** Sedation with Midazolam

## Key facts

- **NCT ID:** NCT01517828
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01517828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01517828, "Intranasal Midazolam Versus Intranasal Ketamine to Sedate Newborns for Intubation in Delivery Room". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01517828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*